Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Dermatology-focused Novan nets $41.9mm in Nasdaq IPO

Executive Summary

Dermatology-focused Novan Inc. (nitric oxide (NO) drug delivery) netted $41.9mm in an initial public offering of 4.1mm shares (upsized from the 3.75mm shares it had planned) priced at $11 (the low end of its anticipated $11-13 range).
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies